Primary Medical Property Ltd (PMP) undertakes the development and management of a specialist healthcare property for retention as investments, and has gross assets of approximately £60m. The Morgan Sindall Group previously had a 47.5% shareholding in PMP.

Initially Morgan Sindall purchased the remaining 52.5% shareholding in PMP from certain oprivate individuals, subsequently the group has agreed to dispose of 50% of its interest by way of entering into a 50-50 owned joint venture agreement with a fund managd by Barclays Private Equity.

Operis project managed and advised Morgan Sindall in relation to this transaction.

 

Share now

CONTACT US

Please get in touch with either of our regional offices.

https://www.operis.com/wp-content/uploads/2022/11/Erwan-1.jpeg
Erwan Fournis
Global Head of Financial Advisory

+44 207 562 0444

[javascript protected email address]
https://www.operis.com/wp-content/uploads/2021/05/Carmen-Wade-500x500.jpg
Carmen Wade
Financial Advisory, Head of North America

+1 647 243 3840

[javascript protected email address]
https://www.operis.com/wp-content/uploads/2021/03/Jun-Tao-500x500.png
Jun Tao
Global Head of Model Audit & Financial Modelling

+44 207 562 0428

[javascript protected email address]
https://www.operis.com/wp-content/uploads/2021/04/019A5891_Michael.jpg
Michael Jarman
Head of Model Development

+1 647 243 8016

[javascript protected email address]
https://www.operis.com/wp-content/uploads/2021/05/Philip-Allen-500x500.jpg
Philip Allen
Head of Training [javascript protected email address]

Operis Europe

View Google Map
+44 207 562 0400
[javascript protected email address]

Operis North America

View Google Map
+1 647 846 7382
[javascript protected email address]

CONTACT US

Discuss your requirements with us

https://www.operis.com/wp-content/uploads/2022/11/Erwan-1.jpeg
Erwan Fournis
Global Head of Financial Advisory

+44 207 562 0444

[javascript protected email address]
https://www.operis.com/wp-content/uploads/2022/11/22_09_Chris_A-0376.jpg
Chris Aldred
Director

+44 207 562 0433

[javascript protected email address]
Name(Required)
Consent(Required)
This field is for validation purposes and should be left unchanged.